Aarti Drugs Share Price

₹ 453.80

+₹18.60 (4.27%)

Last updated 02 Nov, 2026, 15:56 IST

NSE: AARTIDRUGS

Aarti Drugs Share Price Today

As of 2 Nov 2026, Aarti Drugs share price is ₹453.80. The stock opened at ₹445.00, compared to its previous close of ₹435.20. During today's trading session, Aarti Drugs share price moved in the range of ₹441.95 to ₹463.50, with an average price of ₹452.73 for the day. Looking at its last 52-week, the stock has touched a low of ₹318.95 and a high of ₹534.00. On the performance front, Aarti Drugs share price has increased by 15.65% over the last six months and is down 13.31% on a year-on-year basis.

₹441.95

4.27% up today

₹463.50

1D LOW

1D HIGH

Aarti Drugs Stock Insights

Latest Earning

Op Profit TrendDown by 1.59% QoQ

Latest Earning

Net Profit TrendUp by 15.97% YoY

Latest Earning

Revenue TrendUp by 6.84% YoY

Stock Performance

OutperformingBeat Nifty by 8.41 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.66%

Shareholding Pattern

DIIDII increased stake by 30.56%

Shareholding Pattern

FIIFII increased stake by 48.25%

Aarti Drugs Stock Insights

Latest Earning

Op Profit TrendDown by 1.59% QoQ

Latest Earning

Net Profit TrendUp by 15.97% YoY

Latest Earning

Revenue TrendUp by 6.84% YoY

Stock Performance

OutperformingBeat Nifty by 8.41 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.66%

Shareholding Pattern

DIIDII increased stake by 30.56%

Shareholding Pattern

FIIFII increased stake by 48.25%

Aarti Drugs stock performance
Open	₹445.00
High	₹463.50
Low	₹441.95
Prev. close	₹435.20

Aarti Drugs trading activity
Volume	7,50,107
Average traded price	₹453.60
Last traded time	03:56:48 02 Nov
Last traded quantity	85

₹348.20₹522.20

Circuit Low

Circuit High

₹318.95₹534.00

52-Week Low

52-Week High

Circuit

₹348.20

₹522.20

52-week

₹318.95

₹534.00

Mkt Cap Cr

3,976.63

P/E

20.81

P/B

2.57

ROA

6.79%

ROE

12.58%

ROCE

11.51%

Quick Ratio

1.06

EV/EBITDA

13.59

Mkt Cap Cr

3,976.63

P/E

20.81

P/B

2.57

ROA

6.79%

ROE

12.58%

ROCE

11.51%

Quick Ratio

1.06

EV/EBITDA

13.59

Based on fundamentals, this stock's

Performance

Excellent

Aarti Drugs outperforming all market indices

Valuation

Overvalued

Aarti Drugs appears overvalued compared to its peers

Earnings

Neutral

Aarti Drugs earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,76,306.21	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,29,242.68	97.0	21.33	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Aarti Drugs Company Background

ISIN

INE767A01016

Sector Market Cap

₹ 3,976.63 Cr

Aarti Drugs Limited is an India-based company, which is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates in the pharmaceuticals segment. Its geographical segments include Out of India and India. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

Aarti Drugs Financial Highlights

Revenue: Aarti Drugs reported revenue of ₹2,567.70 crore in FY26 vs ₹2,403.39 crore in FY25. It showed an increase of 6.84% on a yearly basis.
Operating Profit: Aarti Drugs reported an operating profit of ₹210.90 crore in FY26 vs ₹211.77 crore in FY25. It showed a decrease of 0.41% on a year-on-year basis.
Net Profit: Aarti Drugs reported a net profit of ₹194.94 crore in FY26 vs ₹168.10 crore in FY25. It showed an increase of 15.97% on a yearly basis.

Aarti Drugs Quarterly Result Highlights

Aarti Drugs reported revenue of ₹703.59 crore in Jun 2026, compared with ₹721.06 crore in Mar 2026, representing a decrease of 2.42% on a quarter-on-quarter (QoQ) basis.
Aarti Drugs reported an operating profit of ₹69.24 crore in Jun 2026, compared with ₹70.36 crore in Mar 2026, representing a decrease of 1.59% on a quarter-on-quarter (QoQ) basis.
Aarti Drugs reported a profit of ₹50.13 crore in Jun 2026, compared with ₹55.26 crore in Mar 2026, reflecting a decrease of 9.28% on a QoQ basis.
The earnings per share (EPS) of Aarti Drugs stood at ₹21.36 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

54.07%

FII

2.26%

Other DII

0.27%

Retail and other

33.43%

Mutual funds

9.97%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	2.15%
Mar 2026	1.58%
Jun 2026	1.52%
Sep 2026	2.26%

Aarti Drugs Investment Returns

1 day

-3.07%

1 week

+16.08%

1 month

+1.00%

1 year

-13.31%

3 years

-6.28%

5 years

-25.68%

Aarti Drugs Share Price History

Aarti Drugs share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
30 Oct 26	₹444.00 / ₹435.20	-3.07%
29 Oct 26	₹440.00 / ₹449.00	+0.25%
28 Oct 26	₹405.00 / ₹447.90	+11.35%
27 Oct 26	₹381.00 / ₹402.25	+6.04%
26 Oct 26	₹374.00 / ₹379.35	+1.19%
23 Oct 26	₹380.25 / ₹374.90	-1.36%
22 Oct 26	₹388.90 / ₹380.05	-2.20%
21 Oct 26	₹396.00 / ₹388.60	-2.68%
19 Oct 26	₹400.00 / ₹399.30	+0.74%
16 Oct 26	₹396.45 / ₹396.35	-0.03%

Aarti Drugs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,565.31	₹2,387.03	₹2,528.58	₹2,716.05
Other Income	₹2.39	₹16.36	₹4.03	₹2.19
Total Revenue	₹2,567.70	₹2,403.39	₹2,532.61	₹2,718.25
Total Expenses	₹2,356.80	₹2,191.62	₹2,297.08	₹2,494.07
Profit Before Tax	₹210.90	₹211.77	₹235.53	₹224.18
Tax	₹15.96	₹43.67	₹63.94	₹57.82
Profit After Tax	₹194.94	₹168.10	₹171.59	₹166.36
EPS - Basic	₹21.36	₹18.35	₹18.65	₹17.97
EPS - Diluted	₹21.36	₹18.35	₹18.65	₹17.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹210.90	₹211.77	₹235.53	₹224.18
Income before WC changes	₹313.66	₹296.11	₹318.54	₹309.33
Change in Assets	-₹87.85	₹47.31	₹195.32	-₹88.60
Change in Liabilities	₹23.63	-₹43.73	-₹92.53	-₹27.74
Change in WC	-₹64.22	₹3.59	₹102.79	-₹116.34
Cash flow from Operations	₹253.54	₹244.58	₹358.92	₹133.32
Cash flow from Investing	-₹173.41	-₹164.63	-₹223.65	-₹163.97
Cash flow from Financing	-₹77.44	-₹82.12	-₹136.03	₹16.54
Total Cash Flow	₹2.69	-₹2.17	-₹0.76	-₹14.11
Cash (Start of the year)	₹4.58	₹6.74	₹7.50	₹21.61
Cash (End of the year)	₹7.27	₹4.58	₹6.74	₹7.50

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,347.49	₹1,236.32	₹1,111.64	₹929.05
Current Assets	₹1,467.77	₹1,338.35	₹1,320.72	₹1,492.35
Total Assets	₹2,815.26	₹2,574.68	₹2,432.36	₹2,421.40
Current Liabilities	₹922.26	₹836.97	₹795.54	₹932.98
Net Current Asset	₹545.52	₹501.39	₹525.18	₹559.37
Non-Current Liabilities	₹343.78	₹368.37	₹354.86	₹295.75
Equity Capital	₹1,549.23	₹1,369.34	₹1,281.95	₹1,192.67
Total Equity & Liabilities	₹2,815.26	₹2,574.68	₹2,432.36	₹2,421.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,260.39	₹2,173.65	₹2,266.91	₹2,497.97
Other Income	₹2.59	₹13.57	₹4.18	₹2.23
Total Revenue	₹2,262.98	₹2,187.23	₹2,271.09	₹2,500.20
Total Expenses	₹2,081.67	₹1,988.47	₹2,078.61	₹2,295.39
Profit Before Tax	₹181.31	₹198.75	₹192.48	₹204.81
Tax	₹12.08	₹41.44	₹50.60	₹52.00
Profit After Tax	₹169.22	₹157.31	₹141.88	₹152.81
EPS - Basic	₹18.54	₹17.18	₹15.43	₹16.50
EPS - Diluted	₹18.54	₹17.18	₹15.43	₹16.50

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹181.31	₹198.75	₹192.48	₹204.81
Income before WC changes	₹266.33	₹268.84	₹270.17	₹283.24
Change in Assets	-₹47.09	₹9.12	₹168.24	-₹76.31
Change in Liabilities	₹24.91	-₹5.92	-₹50.08	₹9.60
Change in WC	-₹22.17	₹3.19	₹118.17	-₹66.71
Cash flow from Operations	₹254.14	₹220.08	₹337.10	₹161.70
Cash flow from Investing	-₹127.58	-₹134.92	-₹187.09	-₹131.14
Cash flow from Financing	-₹126.27	-₹84.60	-₹148.81	-₹30.54
Total Cash Flow	₹0.29	₹0.56	₹1.20	₹0.03
Cash (Start of the year)	₹3.28	₹2.72	₹1.52	₹1.49
Cash (End of the year)	₹3.57	₹3.28	₹2.72	₹1.52

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,168.84	₹1,092.23	₹990.60	₹845.96
Current Assets	₹1,212.76	₹1,180.56	₹1,181.02	₹1,349.53
Total Assets	₹2,381.60	₹2,272.79	₹2,171.62	₹2,195.50
Current Liabilities	₹712.63	₹705.79	₹684.60	₹847.39
Net Current Asset	₹500.12	₹474.77	₹496.42	₹502.14
Non-Current Liabilities	₹264.18	₹315.65	₹311.81	₹233.80
Equity Capital	₹1,404.79	₹1,251.35	₹1,175.21	₹1,114.30
Total Equity & Liabilities	₹2,381.60	₹2,272.79	₹2,171.62	₹2,195.50